November 19, 2025Synact Pharma: CBO Mads Bjerregaard presents at Redeye Theme Event Autoimmune & Inflammatory Diseases
November 13, 2025BioStock Life Science Summit 2025
October 29, 2025ØU Life Science - Synact Pharma præsentation (in Danish)
October 3, 2025Company presentation
June 4, 2025Capital Markets Day 2025
June 3, 2025Latest Company Presentation
November 20, 2024Synact Pharma: CSO Thomas Jonassen presents at Redeye Autoimmune & inflammatory diseases event
October 30, 2024Økonomisk Ugebrev’s Life Science investor conference (in Danish)
September 6, 2024CEO Torbjørn Bjerke at Börsveckan’s Seminar (Swedish)
May 22, 2024Presentation at Sedermeradagen Stockholm 2024
February 23, 2024Interim Report Q4 2023 – Presentation
November 24, 2023Finwire TV – CEO Torbjørn Bjerke comments on the recent development
October 24, 2023Interim Report Q3 2023 – Presentation
October 3, 2023SynAct Pharma – EXPAND Study Update
September 13, 2023EXPAND study update
September 4, 2023Direkt: Comment on the EXPAND top line data presented today
September 4, 2023Presentation regarding the announced top line data from the 12-week EXPAND P2b clinical trial in severely active newly diagnosed rheumatoid arthritis patients
August 4, 2023Interim Report Q2 2023 – Presentation
June 6, 2023SynAct Pharma presentation at the 2023 BIO International Convention
May 30, 2023SynAct presenting at Biostock Life Science Summit – May 30, 2023
May 30, 2023SynAct presenting at ABGSC Life Science Summit
April 3, 2023Direkt: Changes to management
April 3, 2023Biostock: About management changes
March 1, 2023Company presentation
February 24, 2023BioStock: Progress for SynAct Pharma in 2022 – more milestones ahead
December 12, 2022Presentation related to TXP Acquisition and Directed Share Issue
August 5, 2022SynAct Pharma Company Presentation August 2022
June 9, 2022Presentation at BioStock Life Science Spring Summit
June 1, 2022Presentation at Life Science Investor Konference, June 1, 2022 – Copenhagen
May 19, 2022Presentation at ABGSC Life Science Summit
March 28, 2022Presentation regarding the Rights Issue 2022
March 21, 2022SynAct Pharma Company Presentation March 2022
February 14, 2022SynAct Pharma Company Presentation February 2022
December 13, 2021SynAct presents at ABGSC’s Investor Conference December 8, 2021
December 7, 2021Company Presentation December 2021
December 2, 2021BEGIN Study Presentation updated with ACR5070
May 25, 2021Presentation at ABGSC Life Science Summit
May 5, 2021Presentation at The Kempen & Co Life Sciences Conference
October 23, 2020Company presentation – October 2020
